| Expression pattern: |
DN |
| Associated gene: |
- |
| Associated microRNA: |
hsa-miR-135b-3p, hsa-miR-298, hsa-miR-485-3p, hsa-miR-182-5p, hsa-miR-593-5p |
| Biological function: |
Proposed diagnostic biomarker; may be linked to apoptosis via FAF1 context. |
| Molecular mechanism: |
Predicted miRNA sequestration via MREs; matched with miR-135b. |
| Biological pathway or process: |
ceRNA regulation (other) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; divergent primers PCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis |
| Clinical significance: |
Highest diagnostic accuracy among the six circRNAs (AUC = 0.78, 95% CI: 0.69-0.88); contributes to combined AUC = 0.82 with hsa_circ_006054 and hsa_circ_406697. |
| Description: |
hsa_circ_100219 (circBase: hsa_circ_0004619) is down-regulated in breast cancer tissues and showed the best diagnostic performance (AUC 0.78) among the tested circRNAs; it is predicted to bind several miRNAs (including miR-135b-3p, miR-298, miR-485-3p). |
| Confidence score: |
0.5963 |